Sec Form 4 Filing - Ripley Anne-Marie Juliette @ SECOND SIGHT MEDICAL PRODUCTS INC - 2015-12-04

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Ripley Anne-Marie Juliette 2. Issuer Name and Ticker or Trading Symbol SECOND SIGHT MEDICAL PRODUCTS INC [ EYES] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) VP of Regulatory Affairs (Last) (First) (Middle) 12744 SAN FERNANDO ROAD, SUITE 400 3. Date of Earliest Transaction (MM/DD/YY) 12/04/2015 (Street) SYLMAR, CA91342 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 12/04/2015 12/04/2015 M 2,500 A $ 4.75 2,500 ( 1 ) D Common Stock 12/04/2015 S 2,500 D $ 5.5 0 ( 1 ) D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Non-Qualified Stock Option (right to buy) $ 4.75 12/04/2015 12/04/2015 M 2,500 01/01/2007 01/01/2016 Common Stock 2,500 $ 0 0 ( 1 ) D Non-Qualified Stock Option (right to buy) $ 5 01/01/2008( 2 ) 01/01/2017 Common Stock 6,125 6,125 D Non-Qualified Stock Option (right to buy) $ 5 04/01/2009( 2 ) 04/01/2018 Common Stock 4,750 4,750 D Non-Qualified Stock Option (right to buy) $ 5 11/01/2009( 2 ) 11/01/2018 Common Stock 25,000 25,000 D Non-Qualified Stock Option (right to buy) $ 5 02/01/2010( 2 ) 02/01/2019 Common Stock 6,750 6,750 D Non-Qualified Stock Option (right to buy) $ 5 02/01/2011( 2 ) 02/01/2020 Common Stock 20,750 20,750 D Non-Qualified Stock Option (right to buy) $ 5 03/01/2012( 2 ) 03/01/2021 Common Stock 8,313 8,313 D Non-Qualified Stock Option (right to buy) $ 5 03/01/2013( 2 ) 03/01/2022 Common Stock 7,750 7,750 D Non-Qualified Stock Option (right to buy) $ 5 04/01/2015( 2 ) 04/01/2024 Common Stock 12,500 12,500 D Non-Qualified Stock Option (right to buy) $ 9 09/26/2015( 2 ) 09/26/2024 Common Stock 72,129 72,129 D Non-Qualified Stock Option (right to buy) $ 13.09 03/25/2016( 2 ) 03/25/2025 Common Stock 6,250 6,250 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Ripley Anne-Marie Juliette 12744 SAN FERNANDO ROAD SUITE 400 SYLMAR, CA91342 VP of Regulatory Affairs Signatures /s/ Anne-Marie Ripley 12/07/2015 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Options were granted o n 1/1/2006 and were set to expire on 1/1/2016. ( 2 )Options vest in 4 yearly increments starting with the Date Exercisable.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.